Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Sten Peder Andersen, Harald Mischak, Petra Zürbig, Hans-Henrik Parving, Peter Rossing

    76 Citationer (Scopus)

    Abstract

    Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the effect of treatment with Irbesartan in type 2 diabetic patients with microalbuminuria on the urinary proteome.
    OriginalsprogEngelsk
    TidsskriftB M C Nephrology
    Vol/bind11
    Sider (fra-til)29
    ISSN1471-2369
    DOI
    StatusUdgivet - 1 jan. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria'. Sammen danner de et unikt fingeraftryk.

    Citationsformater